Please login to the form below

Not currently logged in
Email:
Password:

KOLs

This page shows the latest KOLs news and features for those working in and with pharma, biotech and healthcare.

GSK to reverse ‘no KOLs’ policy, admitting it has hit marketing

GSK to reverse ‘no KOLs’ policy, admitting it has hit marketing

Company seeking to revive lacklustre marketing performance. GlaxoSmithKline is to reverse its ban on paying healthcare professionals and key opinion leaders (KOLs), admitting that the policy has hit awareness of its ... GSK says it will now return to

Latest news

  • Taming the Monster Taming the Monster

    physicians and KOLs.

  • Signal strength Signal strength

    Certainly, as companies seek to build reputation and trust amongst KOLs, medical affairs teams will be central to demonstrating the transparency, scientific rigour and medical accountability that should underpin every communication

  • Harnessing the unrivalled power of key opinion leaders Harnessing the unrivalled power of key opinion leaders

    Indeed, many pharma companies have been shown to wait until phase III has started before approaching KOLs. ... For example, some KOLs may be experts in clinical trial design while others might excel in public speaking.

  • Back to the future Back to the future

    For example, market access and KOL management are secondary to channel management and branding.

  • Connected Healthcare Connected Healthcare

    Despite the inexorable shift to digital, Cello's research has found that information received face-to-face from peers, key opinion leaders (KOLs), pharma sales representatives and sponsored conferences remain the

More from news
Approximately 2 fully matching, plus 105 partially matching documents found.

Latest Intelligence

  • Nudge-nudge, think-think Nudge-nudge, think-think

    It’s a classic ‘nudge’. The principle is at the root of KOL work – but it applies equally to patients.

  • Developing advocacy in the pharmaceutical industry Developing advocacy in the pharmaceutical industry

    Programme types are multiple and varied, and if you have a KOL or group of KOLs in mind, it is important to match your programme with their strengths and career status. ... But if you or your company is new to a therapy area, you may wish to use KOL

  • Understanding HCPs to build a meaningful brand Understanding HCPs to build a meaningful brand

    Conversely, your existing Key Opinion Leaders (KOLs) are already trusted among their peers but might appreciate help from their peers in developing their online networks. ... Consider empowering your existing KOLs to engage online. 3. Listen and learn.

  • Accelerating diagnosis in rare disease Accelerating diagnosis in rare disease

    Companies can help raise disease awareness by engaging with key opinion leaders (KOLs) and driving impactful campaigns using a multichannel communication approach. ... Scientific meetings are a valued source of learning among HCPs as they allow for

  • A marathon and a sprint A marathon and a sprint

    At Lucid, we did it with oncology KOLs at a European congress. ... Although the congress had over 1, 000 delegates, the experience we created targeted only the top 15 KOLs in the therapy area.

More from intelligence
Approximately 7 fully matching, plus 31 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 49 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

04 A Healthy Ambience
Creating a Lifeline to the New Digital User...
03 Health Services
How Pharma Companies Can Survive the Patent Cliff Through Digital Innovation...
From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...

Infographics